High-affinity monoclonal IgG 
that monoclonal IgM antibodies against HBsAg (anti-HBs) coupled to a solid-phase support quantitatively bound more HBsAg at a faster rate than conventionally prepared anti-HBs reagents or other high-affinity IgG monoc lon anti-HBs antibodies. Consequently, IgM anti-HBs was also radiolabeled, and an IgM-IgM radioimmunoassay was developed for the immunodiagnosis of hepatitis B. The lower limit of this assay was -100 pg ± 30 (SEM) of HBsAg per ml of serum. Compared to available commercial radioassays, preliminary studies have shown the IgM-IgM assay to have increased sensitivity, which improved the detection of a HBsAg-associated determinant in acute hepatitis and post transfusion hepatitis. It is probable that the multivalent interaction between monoclonal IgM anti-HBs and the polydeterminant HBsAg is important in augmenting the performance of this monoclonal assay.
Acute hepatitis B causes significant mortality and morbidity, and chronic infection with the virus is associated with hepatocellular carcinoma, chronic active hepatitis, and cirrhosis (1) . The specific viral marker for acute and chronic hepatitis B infection is the presence of hepatitis B surface antigen (HBsAg) in the blood (2) . This high molecular weight complex viral protein is a surface component of the intact 42-nm hepatitis virus, but it is also present on a circulating 22-nm particle (3) . HBsAg is distinct from other hepatitis B-associated antigens such as hepatitis B core antigen and hepatitis B e antigen (4, 5) . In some patients, the amount of HBsAg in the blood reaches exceedingly high levels and may be measured by simple Ouchterlony gel diffusion (6) . In most individuals, more sensitive techniques such as radioimmunoassays are required for detection of HBsAg (7) . There may be others, however, in whom the virus or viral proteins are present but undetectable by the most sensitive currently available methods.
In the present investigation we have explored the use of highaffinity monoclonal antibodies directed towards epitopes on hepatitis B surface antigen (anti-HBs) in the immunodiagnosis of hepatitis B. A radioimmunoassay using IgM anti-HBs was constructed that demonstrated enhanced sensitivity compared to existing commercial assays. The multivalent nature of the IgM-HBsAg interaction probably played a role in improving assay performance.
MATERIALS AND METHODS
Establishment of Somatic Cell Hybrids Producing Monoclonal Antibodies to HBsAg. The preparation of immunizing antigen, immunization schedule, cell fusion techniques, and culture of somatic cell hybrids have been described (8) (9) (10) (11) (12) . Hybridomas were cloned twice at limiting dilutions (by use of Poisson statistics) on BALB/c 3T3 monolayers. After dilutional cloning, we selected three IgM-and two IgG-producing cell lines with high anti-HBs binding activity for intraperitoneal injection (4 X 106 cells) into pristane-primed BALB/c mice. Subsequently, the ascites fluid was collected and analyzed as described below.
Analysis and Properties of Anti-HBs Activity. Three separate assays were used for measurement of anti-HBs activity in cell culture supernatants and in ascites fluid. The first procedure involved a modification of the AUSAB (Abbott) solid-phase radioimmunoassay. Two hundred microliters of culture medium or ascites fluid was incubated with HBsAg-coated beads for 24 hr at room temperature followed by extensive washing with distilled water. Then "2I-labeled HBsAg ('25I-HBsAg; 1.3 x 105 cpm) was added, the beads were again extensively washed with distilled water, and radioactivity was measured in a Packard gamma well counter. Binding of labeled antigen in excess of 2.5 times background was taken as an indication of the presence of specific antibody. The second solid-phase radioimmunoassay used "2I-labeled goat anti-mouse F(ab') and was identical to the one mentioned above except that 'AI-labeled goat anti-mouse F(ab')2 (1 x 105 cpm) was added in place of '"IHBsAg (13) . Finally, the capability of anti-HBs to agglutinate HBsAg-coated (ayw and adw subtypes) human 0-negative erythrocytes in a microhemagglutination reaction was also evaluated (14) .
Isotype analysis of anti-HBs was performed on the five double-cloned cell lines designated as 5D3, 2F11, 1F8, 1C7, and 4E8. In these experiments, 200 ,ul of culture supernatant was incubated with HBsAg-coated beads for 24 hr followed by extensive washing with distilled water. The second probes, '"I- Preliminary studies demonstrated that the sera from 8 of 22 patients with post-transfusion hepatitis, all of whom were negative for anti-HBs and HBsAg by two commerical and the control radioimmunoassays, were positive in the IgM-IgM monoclonal assay. Furthermore, five of these eight sera had high-titer anti-HBc antibodies, providing further serologic evidence that these patients had a prior hepatitis B infection (19) . In 20 consecutive patients with presumed acute viral hepatitis, 10 were positive for HBsAg by both commercial and monoclonal assays; but in 5 others of this group, 3 of whom were positive for anti-HBc, a positive detection of HBsAg was obtained only by the IgM-IgM monoclonal system.
DISCUSSION
Five cloned hybridoma cell lines have been established which are stable and retain their capability to produce specific antibodies to antigenic components of HBsAg. Cloned cell lines 2F11, 1F8, and 5D3 produced IgM anti-Hl3s, and 1C7 and 4E8 produced IgG anti-HBs. Further, the specificity for HBsAg of the monoclonal IgG and IgM anti-HBs was explored by three independent measurements: two solid-phase radioimmunoassays and a-microhemagglutination reaction. There is little doubt that the monoclonal IgG and IgM produced as the result of fusing NS1 myeloma cells with HBsAg-primed splenocytes possessed specificity for the yet to be defined antigenic components unique to HBsAg (20) .
Ascites fluid derived from the five cell lines contained antibody that bound to HBsAg with extraordinary avidity (Table   1 ). The binding avidities of the IgM anti-HBs, especially the 5D3 antibody were particularly striking. Because most naturally occurring IgM antibodies have low avidity (21, 22) , the multivalent nature of these antibodies and repeating epitopes on HBsAg undoubtedly contribute to their remarkable binding activity (23, 24) .
In an attempt to develop radioimmunoassays using monoclonal anti-HBs, it was important to establish that the antibodies could be linked to a solid-phase support and still maintain their HBsAg-binding characteristics. Fig. 1 indicates that two IgM anti-HBs were superior to the other monoclonal antibodies and a commercial reagent in this regard. When the monoclonal antiHBs antibodies were radiolabeled with "2I and the binding to HBsAg on a solid-phase support was assayed, an IgM anti-HBs performed better than the other antibodies at all time points (Fig. 2) .
Initially, we used the 5D3 IgM anti-HBs immobilized in a solid phase. After incubation of this solid phase with HBsAgpositive standards, the support was washed. Monoclonal IgG '"I-labeled anti-HBs were selected for use as the indicating antibodies in this "forward sandwich assay" because it seemed likely that they were directed towards different epitopes on HBsAg. This assay procedure proved successful, but the lower limit of sensitivity was only 5 ng of HBsAg per ml. Moreover, the performance of the assay was not enhanced by simultaneous addition of both high-affinity IgG monoclonal "2I-labeled antiHBs. Relatively higher concentrations of HBsAg (>10 ng/ml) were easily detected by the assays. One possible explanation for these observations is that the IgG monoclonal antibodies were directed towards relatively low-density epitopes on HBsAg. As the concentration of HBsAg is progressively lowered by serial dilution, one would expect the binding to HBsAg by the highly specific IgG monoclonal antibodies to be limited by the number of available epitopes.
The most sensitive assay design for measurement of HBsAg was the use of monoclonal IgM-IgM. This assay was capable of detecting approximately 100 pg ± 30 (SEM) of HBsAg per ml. It was somewhat surprising that the 5D3 IgM-IgM solid-phase radioimmunoassay could detect HBsAg, especially at low concentrations. In the reverse and simultaneous assays, the IgM on the solid phase and the IgM "WI-labeled anti-HBs indicator probe are identical and compete for the same epitope. Consequently, one might have expected a blocking reaction which could restrict the performance of the assay at lower concentrations of HBsAg. However, a total 5D3 IgM monoclonal system proved to be the best design with respect to enhanced sensitivity. These experiments suggest that the monoclonal IgM derived from cell line 5D3 must be directed toward a highly represented epitope on HBsAg. Under these circumstances, the multivalent interaction of the IgM with a high-density repeating epitope was possible and presumably contributed to enhanced sensitivity in accord with theoretical determinations of Crothers and Metzger (22) and Ehrlich (24) .
In some patients with acute hepatitis and posttransfusion hepatitis, the monoclonal assay detected an HBsAg-associated determinant not detected with a highly sensitive commercial assay (AUSRIA II). Thus, it would appear that one can take advantage of the special characteristics of this antibody (namely, multivalency, high affinity, and common epitope recognition) in the construction of a highly sensitive radioimmunoassay for hepatitis B. The efficacy of the monoclonal IgM-IgM assay reported here must now be demonstrated by more extensive trials.
